Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, OntarioDr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.
Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.
Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.
Disclosures
- Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics
Recent Contributions to PracticeUpdate:
- Clinical Characteristics of Deceased COVID-19 Patients in China
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- Clinical Characteristics of Deceased Patients With COVID-19
- Are Patients With Hypertension and Diabetes Mellitus at Increased Risk for COVID-19 Infection?
- SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
- WHO Declares Coronavirus a Pandemic
- Outcomes Associated With Oral Anticoagulants Plus Antiplatelets for Newly Diagnosed Atrial Fibrillation
- Comparison of Cardiovascular Events Among Users of Different Classes of Antihypertension Medications
- Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide in Hypertension
- The Impact of Dietary Supplement Use on Survival Outcomes in Breast Cancer